http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108929912-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108929912-B |
| titleOfInvention | A primer, kit and method for screening acute myeloid leukemia |
| abstract | The present invention relates to a primer, a kit and a method for screening acute myeloid leukemia, the primer comprising the gene fragment for amplifying site rs2297141 as described in SEQ ID NO.1 and SEQ ID NO.2 Primer pair; primer pair for amplifying the gene fragment of site rs6576776 as set forth in SEQ ID NO.3 and SEQ ID NO.4. The kit contains the above primers, and the method is used to assess the susceptibility risk of acute myeloid leukemia by detecting the variation of the SNP sites rs2297141 and rs6576776 of the human CCN1 gene. The present invention realizes detection and analysis of single nucleic acid polymorphism of rs2297141 and rs6576776 through the primer pair of reagents used to amplify the gene fragments of rs2297141 and rs6576776, and realizes early screening and easy detection of acute myeloid leukemia in Han population. Perceptual risk assessment. |
| priorityDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 139.